105 related articles for article (PubMed ID: 26130523)
1. The thioredoxin reductase--Thioredoxin redox system cleaves the interchain disulphide bond of botulinum neurotoxins on the cytosolic surface of synaptic vesicles.
Pirazzini M; Azarnia Tehran D; Zanetti G; Lista F; Binz T; Shone CC; Rossetto O; Montecucco C
Toxicon; 2015 Dec; 107(Pt A):32-6. PubMed ID: 26130523
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins.
Pirazzini M; Azarnia Tehran D; Zanetti G; Megighian A; Scorzeto M; Fillo S; Shone CC; Binz T; Rossetto O; Lista F; Montecucco C
Cell Rep; 2014 Sep; 8(6):1870-1878. PubMed ID: 25220457
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of botulinum neurotoxins interchain disulfide bond reduction prevents the peripheral neuroparalysis of botulism.
Zanetti G; Azarnia Tehran D; Pirazzini M; Binz T; Shone CC; Fillo S; Lista F; Rossetto O; Montecucco C
Biochem Pharmacol; 2015 Dec; 98(3):522-30. PubMed ID: 26449594
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 and Thioredoxin-Thioredoxin Reductase enable the catalytic activity of Clostridial neurotoxins inside nerve terminals.
Pirazzini M; Azarnia Tehran D; Zanetti G; Rossetto O; Montecucco C
Toxicon; 2018 Jun; 147():32-37. PubMed ID: 29111118
[TBL] [Abstract][Full Text] [Related]
5. The thioredoxin reductase-thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals.
Pirazzini M; Bordin F; Rossetto O; Shone CC; Binz T; Montecucco C
FEBS Lett; 2013 Jan; 587(2):150-5. PubMed ID: 23178719
[TBL] [Abstract][Full Text] [Related]
6. The role of the single interchains disulfide bond in tetanus and botulinum neurotoxins and the development of antitetanus and antibotulism drugs.
Rossetto O; Pirazzini M; Lista F; Montecucco C
Cell Microbiol; 2019 Nov; 21(11):e13037. PubMed ID: 31050145
[TBL] [Abstract][Full Text] [Related]
7. Redox regulation of botulinum neurotoxin toxicity: therapeutic implications.
Montal M
Trends Mol Med; 2014 Nov; 20(11):602-3. PubMed ID: 25242227
[TBL] [Abstract][Full Text] [Related]
8. Challenges in searching for therapeutics against Botulinum Neurotoxins.
Pirazzini M; Rossetto O
Expert Opin Drug Discov; 2017 May; 12(5):497-510. PubMed ID: 28271909
[TBL] [Abstract][Full Text] [Related]
9. Hsp90 is involved in the entry of clostridial neurotoxins into the cytosol of nerve terminals.
Azarnia Tehran D; Pirazzini M; Leka O; Mattarei A; Lista F; Binz T; Rossetto O; Montecucco C
Cell Microbiol; 2017 Feb; 19(2):. PubMed ID: 27404998
[TBL] [Abstract][Full Text] [Related]
10. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
[TBL] [Abstract][Full Text] [Related]
11. Reductive cleavage of tetanus toxin and botulinum neurotoxin A by the thioredoxin system from brain. Evidence for two redox isomers of tetanus toxin.
Kistner A; Habermann E
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):227-34. PubMed ID: 1570025
[TBL] [Abstract][Full Text] [Related]
12. Association of botulinum neurotoxins with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Toxicon; 2009 Oct; 54(5):570-4. PubMed ID: 19362106
[TBL] [Abstract][Full Text] [Related]
13. The long journey of botulinum neurotoxins into the synapse.
Rummel A
Toxicon; 2015 Dec; 107(Pt A):9-24. PubMed ID: 26363288
[TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxins: mechanism of action.
Tighe AP; Schiavo G
Toxicon; 2013 Jun; 67():87-93. PubMed ID: 23201505
[TBL] [Abstract][Full Text] [Related]
15. Molecular components required for resting and stimulated endocytosis of botulinum neurotoxins by glutamatergic and peptidergic neurons.
Meng J; Wang J; Lawrence GW; Dolly JO
FASEB J; 2013 Aug; 27(8):3167-80. PubMed ID: 23640057
[TBL] [Abstract][Full Text] [Related]
16. Synaptic vesicle chips to assay botulinum neurotoxins.
Ferracci G; Miquelis R; Kozaki S; Seagar M; Lévêque C
Biochem J; 2005 Nov; 391(Pt 3):659-66. PubMed ID: 16011482
[TBL] [Abstract][Full Text] [Related]
17. Cellular Protection of SNAP-25 against Botulinum Neurotoxin/A: Inhibition of Thioredoxin Reductase through a Suicide Substrate Mechanism.
Seki H; Xue S; Pellett S; Šilhár P; Johnson EA; Janda KD
J Am Chem Soc; 2016 May; 138(17):5568-75. PubMed ID: 27070533
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of action of botulinum toxins and neurotoxins].
Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxins: mechanisms of action, antinociception and clinical applications.
Wheeler A; Smith HS
Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179
[TBL] [Abstract][Full Text] [Related]
20. Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
Poulain B; Popoff MR
Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30641949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
